NCT04118777 is a NA clinical trial of Ropivacaine in Pelvic Pain, sponsored by University of Tennessee, Chattanooga.

Who is sponsoring NCT04118777?

NCT04118777 is sponsored by University of Tennessee, Chattanooga.

What drugs are being tested in NCT04118777?

Interventions in NCT04118777: Ropivacaine.

What condition does NCT04118777 study?

NCT04118777 studies Pelvic Pain, Endometriosis, Pelvic Prolapse.

Is NCT04118777 still recruiting?

NCT04118777 is currently withdrawn. Last updated 20 July 2021.

Last reviewed 2021-07-20 · How we verify

NCT04118777

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery

Withdrawn NA Last updated 20 July 2021

What this trial tests

NA trial testing Ropivacaine in Pelvic Pain. Withdrawn.

Timeline

1 May 2020

Primary endpoint
30 June 2020

30 July 2020

Quick facts

Lead sponsor	University of Tennessee, Chattanooga
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Start date	1 May 2020
Primary completion	30 June 2020
Estimated completion	30 July 2020

Drugs / interventions tested

Ropivacaine (ROPIVACAINE) — full drug profile →

Conditions studied

Pelvic Pain — all drugs for Pelvic Pain →
Endometriosis — all drugs for Endometriosis →
Pelvic Prolapse — all drugs for Pelvic Prolapse →

Sponsor

University of Tennessee, Chattanooga

Who can join

Adults 18 to 65, female only, with Pelvic Pain or Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a prospective, randomized, double blinded placebo-controlled study at Erlanger hospital. Eligible patients who provide consent will be randomized into one of two arms receiving continuous intra-peritoneal local anesthetic with 0.2% Ropivacaine or saline.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ropivacaine

Trials testing the same drug.

NCT07116343 — Intrapleural Ropivacaine Infusion in Cardiac Surgery · Phase 4 · recruiting
NCT07209345 — Pre-emptive Scalp Infiltration With Low-dose Flurbiprofen and Ropivacaine for Postoperative Analgesia After Craniotomy · NA · recruiting
NCT05642026 — INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures · Phase 4 · recruiting
NCT07013526 — Dexmedetomidine as Adjuvant for Suprazygomatic Maxillary Nerve Block in Children's Adenotonsillectomy · NA · not yet recruiting
NCT06925789 — Influence of Standardized Perioperative Anesthetic, Analgesic Care on Outcome of Patients Undergoing Hip Fracture Surger · Phase 1 · withdrawn

Other recruiting trials for Pelvic Pain

Currently open trials in the same condition.

NCT07241637 — Effect of Tele-Yoga on Pain, Fatigue, and Quality of Life in Endometriosis · NA · recruiting
NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT06921174 — Comparison of the Effectiveness of Classical Perineal Massage Therapy Versus the Use of an Intravaginal Device to Reduce · Phase 2 · recruiting
NCT06549985 — Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain · NA · recruiting
NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting

Other University of Tennessee, Chattanooga trials

Trials by the same sponsor.

NCT02311296 — Reduced Ventilator-Free Days and Bacterial Colonization of Sub-Glottic Secretions · withdrawn
NCT00793013 — Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation · Phase 2 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04118777 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Tennessee, Chattanooga
Last refreshed: 20 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04118777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing